About
Cartiva, Inc. is a medical device company based in Alpharetta, Georgia, specializing in synthetic cartilage implants for treating osteoarthritis, particularly in the joints of the extremities. Founded in 2011 as a spin-off from research at Georgia Tech, Cartiva employs between 11 and 50 people. The company's flagship product is an FDA-approved synthetic cartilage implant made from polyvinyl alcohol, which mimics natural cartilage and provides a durable, low-friction surface for joints like the great toe. The implant is designed to preserve joint motion and reduce pain, offering an alternative to traditional joint fusion surgeries. Cartiva also focuses on developing additional applications of its technology for other joints, including the thumb, ankle, elbow, and shoulder, and is pursuing FDA approvals for these uses. The company primarily serves orthopedic surgeons in the U.S., aiming to provide patients with effective treatment options for osteoarthritis.
Technologies
Keywords
Company Information
-
Employees 8
-
Founded 2011
-
Annual Revenue $29837000
-
Total Funding $29800000
Location
6120 Windward Parkway, Alpharetta, Georgia, United States, 30005